Pevesa
Stage
Acquired | AcquiredTotal Raised
$2.05MAbout Pevesa
Pevesa is a biotechnology-based company, focused in work with proteins to obtain Isolate, hydrolysates, peptides and amino acids is one of its main tools the biological catalyzers, the enzymes. The stronger ones of Pevesa is the development of custom made products with specific characteristics for each client, and its objective, to become a reference in custom made products in sectors as follows: food; nutraceutical; fermentations and media culture; cosmetic; and bio-agriculture. On November 6, 2019, Pevesa was acquired by Kerry, terms of the agreement were not disclosed.
Missing: Pevesa's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Pevesa's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Pevesa
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pevesa is included in 1 Expert Collection, including Agriculture Technology (Agtech).
Agriculture Technology (Agtech)
1,925 items
Companies that are using technology to make farms more efficient.
Pevesa Patents
Pevesa has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/10/2016 | Ion channel toxins, Neurotoxins, Bacterial toxins, Invertebrate toxins, Mycotoxins | Application |
Application Date | 11/10/2016 |
|---|---|
Grant Date | |
Title | |
Related Topics | Ion channel toxins, Neurotoxins, Bacterial toxins, Invertebrate toxins, Mycotoxins |
Status | Application |
Latest Pevesa News
Mar 26, 2020
Kerry Group Acquires Spanish Plant-Based Biotech Company Pevesa ©Pevesa Food giant Kerry Group has recently announced the acquisition of Pevesa Biotech , a Spanish specialist in non-allergenic and organic plant proteins. The acquisition is designed to strengthen Kerry’s leading position in hydrolysed plant proteins for specialty nutrition Pevesa Biotech is an established supplier of non-allergenic, non-GM plant proteins for infant, general and clinical nutrition. Pevesa’s offering includes high-quality plant proteins such as organic rice and pea protein s and protein hydrolysates. Pevesa has also developed a range of organic and standard organic fertilizers for fruit, olive and specialized nurseries and has for many years been strongly focused on developing sustainable solutions to key nutrition, health, biowaste and agricultural challenges. “Kerry is delighted to bring the global expertise of Pevesa to our leading plant protein portfolio,” said John Reilly, VP Business Development Proteins at Kerry. “Kerry was selected by Pevesa for its expertise, innovation, leadership in producing quality products and patented technology in the non-allergenic plant protein market. It is the perfect complement to Kerry’s growing plant protein product portfolio and customers will benefit from the synergy between Pevesa’s market leading technology and Kerry’s protein processing expertise.” Share article:
Pevesa Frequently Asked Questions (FAQ)
Where is Pevesa's headquarters?
Pevesa's headquarters is located at Avda de la Industria s/n, P.I Poliviso, Sevilla.
What is Pevesa's latest funding round?
Pevesa's latest funding round is Acquired.
How much did Pevesa raise?
Pevesa raised a total of $2.05M.
Who are the investors of Pevesa?
Investors of Pevesa include Kerry Group, Caixa Capital Risc, Suanfarma and Milar Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.